Pomalidomide

Pomalyst

Thalidomide Analog

NADAC/unit N/A

No Shortage Tier 1: 71.7% PA Req: 397.6% 5 Manufacturers 20 ANDAs

a thalidomide analogue indicated for the treatment of adult patients: in combination with dexamethasone, for patients with multiple myeloma (MM) who have received at least two prior therapies inclu....

Covered Lives

Generic Manufacturers

APOTEX INCBRECKENRIDGE PHARMACEUTICAL INCBRISTOL MYERS SQUIBB COEUGIA PHARMA SPECIALITIES LTDHETERO LABS LTD UNIT VTEVA PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Pomalidomide drfinder.aiFind doctors who prescribe Pomalidomide rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Pomalidomide

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.